Weili Medical's announcement on the remuneration plan for directors and senior managers in 2026
Securities code: 603309 Securities abbreviation: Weili Medical Announcement number: 2026-019
Guangzhou Weili Medical Equipment Co., Ltd.
Announcement on the 2026 Remuneration Plan for Directors and Senior Management
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
In order to further standardize the salary management and performance appraisal of directors and senior managers of Guangzhou Weili Medical Devices Co., Ltd. (hereinafter referred to as the "Company" and "Weili Medical"), encourage and constrain directors and senior managers to work diligently and responsibly, and promote the company's steady and sustainable development, in accordance with the relevant laws and regulations, departmental regulations, normative documents such as the Company Law and the Code of Governance for Listed Companies, as well as the relevant provisions of the Articles of Association and the Remuneration Management Measures for Directors and Senior Managers of the Company, the Company 2026 is specially formulated Annual remuneration package for directors and senior management. The specific situation is as follows:
1. 2026 Remuneration Plan for Directors and Senior Management
(1) Applicable objects
Directors of the company and senior managers specified in the Articles of Association.
(2) Applicable period
January 1, 2026 to December 31, 2026. The senior management remuneration plan will be implemented after review and approval by the company's board of directors, and the director's remuneration plan will be implemented after review and approval by the company's shareholders' meeting.
(3) Salary plan
- Director
(1) Non-independent directors
The remuneration composition and performance appraisal of the company's chairman are based on the remuneration standards for senior managers; the remuneration of directors who hold actual positions in the company is determined in accordance with the remuneration system corresponding to their positions in the company. (2) Independent directors
The company's independent directors implement a fixed allowance system, with the allowance being RMB 100,000 per year.
- Senior managers
The remuneration of the company's senior managers consists of basic salary, performance pay and medium- and long-term incentive income:
(1) Basic salary: determined based on the positions, responsibilities, abilities, market salary trends and other factors of senior managers, and paid on a monthly basis;
(2) Performance compensation: Based on the completion of the company's business goals and personal goals, it will be paid based on the results of the annual performance appraisal. In principle, the proportion of performance pay shall not be less than 50% of the total basic salary and performance pay;
(3) Medium- and long-term incentive income: Medium- and long-term incentives include stock options, restricted stocks, employee stock ownership plans and other incentive methods implemented by the company based on actual operating performance, and are income linked to the company's medium- and long-term operating performance and to the results of medium- and long-term performance appraisals. The specific plan will be determined separately in accordance with relevant national laws and regulations.
2. Other instructions
The remuneration paid by the company to directors and senior managers is the actual amount after deducting taxes and payments that should be borne by individuals. The company will withhold and pay personal income tax, individual contributions to various social insurances, and other payments that should be borne by individuals in accordance with relevant national and company regulations.
If the company's directors and senior managers leave office due to reasons such as change of office, re-election, normal resignation, etc., their remuneration will be calculated and paid based on their actual term of office; if the company's directors and senior managers remuneration management system
If a person leaves his post under the circumstances specified in Articles 19 and 21, the company may deduct or stop paying his unpaid salary, allowances and medium- and long-term incentive income according to the severity of the case.
- Matters not covered in the above plan shall be implemented in accordance with the provisions of national laws, administrative regulations, departmental rules, normative documents, the "Articles of Association", "Company Directors and Senior Management Remuneration Management System", etc.
3. Approval Procedure
The company held the fifth meeting of the Remuneration and Assessment Committee of the fifth board of directors and the 20th meeting of the fifth board of directors on April 22, 2026, and reviewed and approved the "Proposal on the Company's 2026 Directors' Remuneration Plan" and the "Proposal on the Company's 2026 Senior Management Remuneration Plan".
Among them, when reviewing the senior management remuneration plan, the related directors have abstained from voting in accordance with regulations; when reviewing the director's remuneration plan, since the proposal involves all directors, the board of directors voted on the proposal item by item, and each director abstained from voting on his or her own remuneration plan. The aforementioned director remuneration plan still needs to be submitted to the company's 2025 annual shareholders' meeting for review.
Announcement is hereby made.
Board of Directors of Guangzhou Weili Medical Devices Co., Ltd.
April 23, 2026